Dornase alfa is well tolerated: data from the epidemiologic registry of cystic fibrosis.

Abstract

After closure of the Epidemiologic Registry of Cystic Fibrosis (ERCF), a comprehensive safety analysis of dornase alfa was performed. A planned subanalysis focused on children under 5 years old. Reported serious adverse events (SAEs) were assigned a preferred term and ascribed to a specific organ system. Possible serious adverse reactions to dornase alfa… (More)

Topics

Cite this paper

@article{McKenzie2007DornaseAI, title={Dornase alfa is well tolerated: data from the epidemiologic registry of cystic fibrosis.}, author={Shona McKenzie and Somshamkar Chowdhury and Birgitta Strandvik and Margaret E. Hodson}, journal={Pediatric pulmonology}, year={2007}, volume={42 10}, pages={928-37} }